|
|
Volumn 334, Issue 2, 1996, Pages 122-123
|
|
Epstein-Barr virus and nasopharyngeal cancer [2]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
TRANSACTIVATOR PROTEIN;
VIRUS ANTIBODY;
VIRUS DNA;
VIRUS PROTEIN;
BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN;
DNA BINDING PROTEIN;
EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS;
EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS;
MATRIX PROTEIN;
EPISOME;
EPSTEIN BARR VIRUS;
HUMAN;
IN SITU HYBRIDIZATION;
LATENT VIRUS INFECTION;
LETTER;
MALIGNANT TRANSFORMATION;
NASOPHARYNX CANCER;
PRIORITY JOURNAL;
VIRUS CELL INTERACTION;
VIRUS EXPRESSION;
CHEMISTRY;
HERPES VIRUS INFECTION;
ISOLATION AND PURIFICATION;
NASOPHARYNX TUMOR;
NOTE;
PRECANCER;
VIROLOGY;
VIRUS INFECTION;
CELL CLONE;
GENETICS;
DNA-BINDING PROTEINS;
HERPESVIRIDAE INFECTIONS;
HERPESVIRUS 4, HUMAN;
HUMANS;
NASOPHARYNGEAL NEOPLASMS;
PRECANCEROUS CONDITIONS;
TRANS-ACTIVATORS;
TUMOR VIRUS INFECTIONS;
VIRAL MATRIX PROTEINS;
VIRAL PROTEINS;
CLONE CELLS;
DNA, VIRAL;
|
|
EID: 0030049350
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199601113340213 Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
